JS
Jeffrey Settleman
About
Dr. Jeff Settleman joined Pfizer in 2019 as the Chief Scientific Officer of the Oncology Research & Development Group.
Investment Focus
Contact Information
linkedin.com/in/••••••••
Find more investors like Jeffrey
Search Investors